Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Patent CN115611756B reveals visible-light synthesis for high-purity agrochemical intermediates, offering cost reduction and scalable supply chain solutions.
Novel green synthesis of risperidone intermediate avoiding POCl3. High yield, scalable process for reliable pharmaceutical intermediate supply.
Patent CN115611756B reveals a visible-light photocatalytic method for α-substituted glycine derivatives, offering mild conditions and scalable agrochemical intermediate manufacturing.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Patent CN114832862A reveals a cost-effective nickel-catalyzed route for fluorinated isoquinoline-1,3-diones, offering significant supply chain advantages for pharmaceutical intermediate manufacturing.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Patent CN112441875B reveals a green copper photocatalytic route for 9-trifluoromethyl-9,10-dihydrophenanthrene, offering mild conditions and high atom economy for pharmaceutical intermediates.
Discover the scalable preparation of Compound A for CNS disorders via optimized Sonogashira coupling. Learn about cost reduction in pharmaceutical manufacturing and supply chain advantages.
Patent CN103992301A reveals iodine-catalyzed chromene synthesis offering cost reduction in pharma intermediate manufacturing and high-purity supply chain reliability.
Patent CN108003156A reveals mild double carbonylation. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN110981823B reveals high-purity triazole synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107400036B reveals Rh-catalyzed route for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain for complex chiral compounds.
Explore patent CN102617487A for novel pyrimidinone compounds. Discover cost-effective synthesis routes and reliable supply chain solutions for HIV-1 integrase inhibitors.
Patent CN108129478B details a copper-catalyzed method for sulfone synthesis using DABSO, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN101759591A reveals a greener Agomelatine synthesis using cyclohexane and one-pot acetylation, offering significant cost reduction and high purity for API manufacturers.
Patent CN101391997B details a safer emtricitabine intermediate synthesis using triphosgene. Discover cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104130206A reveals high-yield 2-butyl-BIT synthesis. Offers cost reduction and supply chain reliability for specialty chemical manufacturing partners globally.
Patent CN101805307B reveals a magnetic nano-catalytic route for tetrazole synthesis, offering high purity, easy separation, and significant cost reduction for pharmaceutical supply chains.
Patent CN109776422A reveals advanced copper-catalyzed asymmetric hydroboration for chiral alkyl borides, offering significant supply chain and cost advantages.